StemGen, Inc. announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced operating loss was USD 57,308 compared to USD 11,786 a year ago. Net loss was USD 98,237 compared to USD 52,703 a year ago. For the nine months, sales was USD 39,000 compared to USD 1,750 a year ago. Operating loss was USD 151,462 compared to USD 45,810 a year ago. Net loss was USD 299,751 compared to USD 168,582 a year ago.